Literature DB >> 12665568

Antithetic effects of MBD2a on gene regulation.

Hidetoshi Fujita1, Ryouji Fujii, Satoko Aratani, Tetsuya Amano, Akiyoshi Fukamizu, Toshihiro Nakajima.   

Abstract

DNA methylation is essential for epigenetic gene regulation during development. The cyclic AMP (cAMP)-responsive element (CRE) is found in the promoter of many cAMP-regulated genes and plays important roles in their gene expression. Methylation occurs on the CRE site and results in transcriptional repression via a direct mechanism, that is, prevention by the methyl group of binding of the cAMP-responsive factor CREB to this site. A recent study indicated that the nucleosome is also important in repressing transcription. In this study, we investigated the regulation of transcriptional repression on methylated CRE. We focused on methyl-CpG binding domain protein 2 (MBD2). MBD2 consists of two forms, MBD2a and MBD2b, the latter lacking the N-terminal extension of MBD2a. Unexpectedly, we found that MBD2a, but not MBD2b, promoted activation of the unmethylated cAMP-responsive genes. An in vivo binding assay revealed that MBD2a selectively interacted with RNA helicase A (RHA), a component of CREB transcriptional coactivator complexes. MBD2a and RHA cooperatively enhanced CREB-dependent gene expression. Interestingly, coimmunoprecipitation assays demonstrated that MBD2a binding to RHA was not associated with histone deacetylase 1. Our results indicate a novel role for MBD2a in gene regulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12665568      PMCID: PMC152551          DOI: 10.1128/MCB.23.8.2645-2657.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  62 in total

Review 1.  Methylation-induced repression--belts, braces, and chromatin.

Authors:  A P Bird; A P Wolffe
Journal:  Cell       Date:  1999-11-24       Impact factor: 41.582

2.  Active repression of methylated genes by the chromosomal protein MBD1.

Authors:  H H Ng; P Jeppesen; A Bird
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

3.  MBD2-MBD3 complex binds to hemi-methylated DNA and forms a complex containing DNMT1 at the replication foci in late S phase.

Authors:  K I Tatematsu; T Yamazaki; F Ishikawa
Journal:  Genes Cells       Date:  2000-08       Impact factor: 1.891

4.  Regulation of Lef-mediated transcription and p53-dependent pathway by associating beta-catenin with CBP/p300.

Authors:  M Miyagishi; R Fujii; M Hatta; E Yoshida; N Araya; A Nagafuchi; S Ishihara; T Nakajima; A Fukamizu
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

Review 5.  Promoter-region hypermethylation and gene silencing in human cancer.

Authors:  J G Herman; S B Baylin
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

6.  Roles of the Dal82p domains in allophanate/oxalurate-dependent gene expression in Saccharomyces cerevisiae.

Authors:  S Scott; A T Abul-Hamd; T G Cooper
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

7.  Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1.

Authors:  I Ohki; N Shimotake; N Fujita; M Nakao; M Shirakawa
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

8.  DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.

Authors:  M Okano; D W Bell; D A Haber; E Li
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

9.  Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription.

Authors:  T Shimohata; T Nakajima; M Yamada; C Uchida; O Onodera; S Naruse; T Kimura; R Koide; K Nozaki; Y Sano; H Ishiguro; K Sakoe; T Ooshima; A Sato; T Ikeuchi; M Oyake; T Sato; Y Aoyagi; I Hozumi; T Nagatsu; Y Takiyama; M Nishizawa; J Goto; I Kanazawa; I Davidson; N Tanese; H Takahashi; S Tsuji
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

10.  Transient depletion of xDnmt1 leads to premature gene activation in Xenopus embryos.

Authors:  I Stancheva; R R Meehan
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

View more
  19 in total

1.  Epigenetic programming of the rRNA promoter by MBD3.

Authors:  Shelley E Brown; Moshe Szyf
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

2.  Epigenetic modulation of insulin-like growth factor-II overexpression by hepatitis B virus X protein in hepatocellular carcinoma.

Authors:  Xu You Liu; Shao Hui Tang; Sheng Lan Wu; Yu Hong Luo; Ming Rong Cao; Hong Ke Zhou; Xiang Wu Jiang; Jian Chang Shu; Cai Qun Bie; Si Min Huang; Zhan Hong Zheng; Fei Gao
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

3.  The implications of DNA methylation for toxicology: toward toxicomethylomics, the toxicology of DNA methylation.

Authors:  Moshe Szyf
Journal:  Toxicol Sci       Date:  2011-02-04       Impact factor: 4.849

4.  The methylated-DNA binding protein MBD2 enhances NGFI-A (egr-1)-mediated transcriptional activation of the glucocorticoid receptor.

Authors:  Ian C G Weaver; Ian C Hellstrom; Shelley E Brown; Stephen D Andrews; Sergiy Dymov; Josie Diorio; Tie-Yuan Zhang; Moshe Szyf; Michael J Meaney
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-09-26       Impact factor: 6.237

5.  The E3 ligase synoviolin controls body weight and mitochondrial biogenesis through negative regulation of PGC-1β.

Authors:  Hidetoshi Fujita; Naoko Yagishita; Satoko Aratani; Tomoko Saito-Fujita; Saori Morota; Yoshihisa Yamano; Magnus J Hansson; Masato Inazu; Hiroko Kokuba; Katsuko Sudo; Eiichi Sato; Ko-Ichi Kawahara; Fukami Nakajima; Daisuke Hasegawa; Itsuro Higuchi; Tomoo Sato; Natsumi Araya; Chie Usui; Kenya Nishioka; Yu Nakatani; Ikuro Maruyama; Masahiko Usui; Naomi Hara; Hiroyuki Uchino; Eskil Elmer; Kusuki Nishioka; Toshihiro Nakajima
Journal:  EMBO J       Date:  2015-02-19       Impact factor: 11.598

6.  Aurora kinase A (AURKA) and never in mitosis gene A-related kinase 6 (NEK6) genes are upregulated in erosive esophagitis and esophageal adenocarcinoma.

Authors:  Elmas Kasap; Seda Örenay Boyacioglu; Mehmet Korkmaz; Elif Saritas Yuksel; Belkis Unsal; Erkan Kahraman; Omer Ozütemiz; Hakan Yuceyar
Journal:  Exp Ther Med       Date:  2012-04-25       Impact factor: 2.447

7.  Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.

Authors:  Imke Müller; Frank Wischnewski; Klaus Pantel; Heidi Schwarzenbach
Journal:  BMC Cancer       Date:  2010-06-17       Impact factor: 4.430

8.  Synergistic effects of combined DNA methyltransferase inhibition and MBD2 depletion on breast cancer cells; MBD2 depletion blocks 5-aza-2'-deoxycytidine-triggered invasiveness.

Authors:  David Cheishvili; Flora Chik; Chen Chen Li; Bishnu Bhattacharya; Matthew Suderman; Ani Arakelian; Michael Hallett; Shafaat A Rabbani; Moshe Szyf
Journal:  Carcinogenesis       Date:  2014-09-01       Impact factor: 4.944

9.  Chromatin composition alterations and the critical role of MeCP2 for epigenetic silencing of progesterone receptor-B gene in endometrial cancers.

Authors:  Yongli Chu; Yanlin Wang; Guanghua Zhang; Haibin Chen; Sean C Dowdy; Yuning Xiong; Fengming Liu; Run Zhang; Jinping Li; Shi-Wen Jiang
Journal:  Cell Mol Life Sci       Date:  2014-02-15       Impact factor: 9.261

10.  In vitro nuclear interactome of the HIV-1 Tat protein.

Authors:  Virginie W Gautier; Lili Gu; Niaobh O'Donoghue; Stephen Pennington; Noreen Sheehy; William W Hall
Journal:  Retrovirology       Date:  2009-05-19       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.